Article

Understanding Emergency Use Authorization (EUA)

Source: Pharmaceutics International

By Veeranna Lolla, RAC, Head of Regulatory Affairs at Pharmaceutics International, Inc (Pii)

iStock-1215516118-fda-approval-medicine-vaccine

COVID-19 has spawned a new vocabulary that includes words like social distancing and zoom meetings. Given the impact of COVID-19 on our lives and our great desire for solutions, public interest in pandemics, mRNA, and vaccine development has been unprecedented.

One of the terms that became part of daily news briefings as drug developers drew closer to an effective vaccine was Emergency Use Authorization (EUA). This is a term we don’t often use, to include those of us who work in the pharmaceutical industry, thankfully, because it is indicative of a public health crisis.

But what exactly is EUA, when is it used, and how does the public health community, FDA, and drug developers authorize emergency use of drugs or other medical products?

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: